JP2016536993A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536993A5
JP2016536993A5 JP2016530177A JP2016530177A JP2016536993A5 JP 2016536993 A5 JP2016536993 A5 JP 2016536993A5 JP 2016530177 A JP2016530177 A JP 2016530177A JP 2016530177 A JP2016530177 A JP 2016530177A JP 2016536993 A5 JP2016536993 A5 JP 2016536993A5
Authority
JP
Japan
Prior art keywords
coli
strain
modified
mutation
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016530177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536993A (ja
JP6545676B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/065545 external-priority patent/WO2015073720A1/en
Publication of JP2016536993A publication Critical patent/JP2016536993A/ja
Publication of JP2016536993A5 publication Critical patent/JP2016536993A5/ja
Application granted granted Critical
Publication of JP6545676B2 publication Critical patent/JP6545676B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016530177A 2013-11-14 2014-11-13 改善された代謝能力を有する細菌 Active JP6545676B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361904298P 2013-11-14 2013-11-14
US61/904,298 2013-11-14
PCT/US2014/065545 WO2015073720A1 (en) 2013-11-14 2014-11-13 Bacteria with improved metabolic capacity

Publications (3)

Publication Number Publication Date
JP2016536993A JP2016536993A (ja) 2016-12-01
JP2016536993A5 true JP2016536993A5 (cg-RX-API-DMAC7.html) 2017-12-28
JP6545676B2 JP6545676B2 (ja) 2019-07-17

Family

ID=53058029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016530177A Active JP6545676B2 (ja) 2013-11-14 2014-11-13 改善された代謝能力を有する細菌

Country Status (4)

Country Link
US (2) US9902965B2 (cg-RX-API-DMAC7.html)
EP (1) EP3068887B1 (cg-RX-API-DMAC7.html)
JP (1) JP6545676B2 (cg-RX-API-DMAC7.html)
WO (1) WO2015073720A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016242996B2 (en) 2015-04-02 2021-02-18 Scarab Genomics, Llc Materials and methods for extended continuous flow fermentation of reduced genome bacteria
IL316539A (en) 2016-03-15 2024-12-01 Rnaissance Ag Llc Methods and compositions for the enhanced production of double-stranded RNA
MX2020002382A (es) 2017-09-05 2021-01-20 Scarab Genomics Llc Métodos y composiciones para mejorar la expresión de proteínas recombinantes.
CN108587992B (zh) * 2018-04-10 2022-03-15 安徽大学 一种高效分泌表达抗VEGF-Fab抗体片段的高产菌株及其构建方法
BR112021024175A2 (pt) * 2019-05-30 2022-04-12 Rnaissance Ag Llc Métodos e composições aprimorados para aumentar a produção de rna fita dupla
WO2021211862A1 (en) * 2020-04-15 2021-10-21 University of Alaska Anchorage Methods and compositions for the production of isobutene
US12168679B2 (en) 2020-11-10 2024-12-17 Northwestern University Modified bacteria for enhanced bioproduction and methods of using the same
CN120882735A (zh) 2023-01-25 2025-10-31 诺韦尔生物技术美国公司 用于产品制造的表达系统

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578464A (en) 1989-10-31 1996-11-26 Schering Corporation E. coli secretory strains
US5747662A (en) 1995-03-01 1998-05-05 Genentech, Inc. Methods and compositions for secretion of heterologous polypeptides
US6022952A (en) 1998-04-01 2000-02-08 University Of Alberta Compositions and methods for protein secretion
US6989265B2 (en) 2002-01-23 2006-01-24 Wisconsin Alumni Research Foundation Bacteria with reduced genome
US8039243B2 (en) 2002-01-23 2011-10-18 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US8119365B2 (en) 2002-01-23 2012-02-21 Wisconsin Alumni Research Foundation Insertion sequence-free bacteria
US7303906B2 (en) 2002-09-06 2007-12-04 Wisconsin Alumni Research Foundation Competent bacteria
US7300776B2 (en) * 2004-04-26 2007-11-27 Ajinomoto Co., Inc. L-amino acid-producing bacterium and a method for producing L-amino acid
US20080009041A1 (en) * 2004-11-26 2008-01-10 Hiroshi Mizoguchi Industrially Useful Microorganism
EP1915445A2 (en) 2005-08-20 2008-04-30 Scarab Genomics, LLC Reduced genome e. coli
JP2009165355A (ja) * 2006-04-28 2009-07-30 Ajinomoto Co Inc Ｌ−アミノ酸を生産する微生物及びｌ−アミノ酸の製造法
WO2007140816A1 (en) * 2006-06-09 2007-12-13 Metabolic Explorer Glycolic acid production by fermentation from renewable resources
JP5778426B2 (ja) * 2008-02-22 2015-09-16 スカラブ ジェノミクス リミティド ライアビリティ カンパニー アミノ酸生合成のための組成物及び方法
EP2298880A4 (en) * 2008-03-18 2012-02-08 Kyowa Hakko Kirin Co Ltd INDUSTRIALLY USEFUL MICROORGANISM
KR20130101030A (ko) * 2010-08-27 2013-09-12 메타볼릭 익스플로러 변형된 미생물을 사용한 개선된 글리콜산 발효 생산
CA2850842C (en) 2011-10-20 2021-06-08 Scarab Genomics, Llc Reduced genome bacteria with improved genetic stability
CA2940316C (en) * 2014-03-03 2022-03-15 Scarab Genomics, Llc Enhanced production of recombinant crm197 in e. coli

Similar Documents

Publication Publication Date Title
JP2016536993A5 (cg-RX-API-DMAC7.html)
PH12018550020A1 (en) Production of human milk oligosaccharides in microbial hosts with engineered import/export
CY1123815T1 (el) Υποκατεστημενες ινδαζολες, διαδικασια για την παρασκευη τους, φαρμακευτικα παρασκευασματα, τα οποια τις περιεχουν, καθως και η χρηση τους για την παρασκευη φαρμακευτικων μεσων
Kubiak et al. Complete genome sequence of Gluconacetobacter xylinus E25 strain—valuable and effective producer of bacterial nanocellulose
JP2014525395A5 (cg-RX-API-DMAC7.html)
CY1120493T1 (el) Πρωτεϊνη συντηξης που περιλαμβανει ιντερλευκινη 4 και ιντερλευκινη 10
ZA202001294B (en) Multispecific antibody
GB2574769A (en) RNA Targeting of mutations via suppressor tRNAs and deaminases
BR112012033699A2 (pt) polipeptídeo tendo atividade beta-glicosidase e seus usos
JP2014530625A5 (cg-RX-API-DMAC7.html)
MX344314B (es) Fucosiltransferasas novedosas y sus aplicaciones.
EA201691990A1 (ru) Получение библиотек вариантов белков, экспрессированных в эукариотических клетках, и применение их для отбора связывающих молекул
JP2017169582A5 (cg-RX-API-DMAC7.html)
BR112012033404A2 (pt) polipetídeo tendo ou auxiliando a atividade de degradação de material de carboidratos e uso dos mesmos.
MX2020002674A (es) Produccion de xilitol a partir de glucosa mediante una cepa recombinante.
MX359953B (es) Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada.
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
WO2014022702A3 (en) Methods and compositions for controlling gene expression by rna processing
BR112015004980A2 (pt) loci de desempenho de fad2 e proteínas-alvo de ligação sítio-específicas correspondentes que têm a capacidade de induzir rompimentos direcionados
MX357484B (es) Cepa con deficit de amilasa.
MX346663B (es) Lineas de celulas de bajo nivel de fucosa y usos de las mismas.
MX2024013590A (es) Adnc del antagonista del receptor de interleucina-1
WO2015199387A3 (ko) 가용성 단백질 발현량 및 활성이 증대된 헬리코박터 파일로리 유래 α-1,3 푸코실 전달효소의 유전자와 단백질 및 α-1,3 푸코실올리고당 생산에의 응용
BR112016020517A2 (pt) método de produção de lipídeo através da utilização de ss-cetoacil-acp sintase
NZ596453A (en) Antibiotic-free plasmid